We’re excited to share our latest progress!
So far, 44 patients have been successfully randomized 🎉
Our network continues to grow, with 18 active sites across 4 countries: Belgium, Germany, New Zealand, Switzerland 🌍
✅ Ethics Committee approval has recently been obtained in Spain and the United Kingdom.
🔜 Trial set-up and EC submissions in Ireland and Australia are currently underway.
More updates coming soon — a big thank-you to all participating teams for helping move this trial forward! 🚀